| Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study SK Mahil, N Dand, KJ Mason, ZZN Yiu, T Tsakok, F Meynell, B Coker, ... Journal of allergy and clinical immunology 147 (1), 60-71, 2021 | 172 | 2021 |
| The prevalence and significance of fissured tongue and geographical tongue in psoriatic patients O Zargari Clinical and experimental dermatology 31 (2), 192-195, 2006 | 150 | 2006 |
| Paederus dermatitis in northern Iran: a report of 156 cases O Zargari, A Kimyai‐Asadi, F Fathalikhani, M Panahi International journal of dermatology 42 (8), 608-612, 2003 | 143 | 2003 |
| Comparison of the efficacy of topical 1% lindane vs 5% permethrin in scabies: A randomized, double-blind study O Zargari, J Golchai, A Sobhani, AR Dehpour, S Sadr-Ashkevari, ... Indian Journal of Dermatology, Venereology and Leprology 72, 33, 2006 | 53 | 2006 |
| Cutaneous adverse reactions to hydroxyurea in patients with intermediate thalassemia O Zargari, A Kimyai‐Asadi, M Jafroodi Pediatric dermatology 21 (6), 633-635, 2004 | 40 | 2004 |
| Pentoxifylline: a drug with wide spectrum applications in dermatology O Zargari Dermatology Online Journal 14 (11), 2008 | 37 | 2008 |
| Ocular findings in patients with psoriasis: is it related to the side effects of treatment or to psoriasis itself? A case-control study F Ghalamkarpour, A Baradaran-Rafii, MM Sadoughi, F Abdollahimajd, ... Journal of Dermatological Treatment 31 (1), 27-32, 2020 | 34 | 2020 |
| Exclusive penile Kaposi's sarcoma: report of an HIV‐negative man successfully treated with radiotherapy O Zargari Journal of the European Academy of Dermatology and Venereology 20 (3), 318-320, 2006 | 31 | 2006 |
| Fox‐Fordyce disease exacerbated by hyperhidrosis A Alikhan, F Gorouhi, O Zargari Pediatric dermatology 27 (2), 162-165, 2010 | 26 | 2010 |
| Soluble biomarkers for diagnosis, monitoring, and therapeutic response assessment in psoriasis MR Pourani, F Abdollahimajd, O Zargari, M Shahidi Dadras Journal of Dermatological Treatment 33 (4), 1967-1974, 2022 | 23 | 2022 |
| High‐sensitivity C‐reactive protein as a biomarker in detecting subclinical atherosclerosis in psoriasis N Niknezhad, HR Haghighatkhah, O Zargari, F Ghalamkarpour, ... Dermatologic Therapy 33 (4), e13628, 2020 | 23 | 2020 |
| Non-psoriatic dermatologic uses of monoclonal antibody therapy ME Sockolov, A Alikhan, O Zargari Journal of dermatological treatment 20 (6), 319-327, 2009 | 20 | 2009 |
| A case of severe psoriatic erythroderma with COVID-19 F Ghalamkarpour, MR Pourani, F Abdollahimajd, O Zargari Journal of Dermatological Treatment 33 (2), 1111-1113, 2022 | 19 | 2022 |
| Correlation between vascular endothelial growth factor and subclinical atherosclerosis in patients with psoriasis M Shahidi‐Dadras, HR Haghighatkhah, F Abdollahimajd, S Younespour, ... International journal of dermatology 55 (1), 52-59, 2016 | 19 | 2016 |
| Punctate porokeratotic keratoderma A Alikhan, T Burns, O Zargari Dermatology Online Journal 16 (1), 2010 | 18 | 2010 |
| Disseminated granuloma faciale O Zargari International journal of dermatology 43 (3), 210-212, 2004 | 18 | 2004 |
| Nail involvement in patients with psoriatic arthritis in Northern Iran O Zargari, EK Leyli, SZ Azimi Autoimmune Diseases 2018, 2018 | 17 | 2018 |
| Clinical applications of topical ivermectin in dermatology O Zargari, N Aghazadeh, F Moeineddin Dermatology Online Journal 22 (9), 2016 | 16 | 2016 |
| Radiation-induced basal cell carcinoma O Zargari Dermatology Practical & Conceptual 5 (2), 109, 2015 | 16 | 2015 |
| The prevalence of scabies in the students of primary schools in somea-sara in 2000-2001: An observational cross-sectional study J Golchai, O Zargari, PM GHOLIPOUR, SM KARBASI IRANIAN JOURNAL OF DERMATOLOGY 7 (1), 29-32, 2003 | 16 | 2003 |
Mohammad Shahidi DadrasSkin Research Center, Shahid Beheshti University of Medical sciences確認したメール アドレス: sbmu.ac.ir
